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Abstract
Weaknesses in health systems contribute to a failure to improve health outcomes in developing countries, despite 
increased official development assistance. Changes in the demands on health systems, as well as their scope to 
respond, mean that the situation is likely to become more problematic in the future. Diverse global initiatives seek to 
strengthen health systems, but progress will require better coordination between them, use of strategies based on the 
best available evidence obtained especially from evaluation of large scale programs, and improved global aid 
architecture that supports these processes. This paper sets out the case for global leadership to support health systems 
investments and help ensure the synergies between vertical and horizontal programs that are essential for effective 
functioning of health systems. At national level, it is essential to increase capacity to manage and deliver services, 
situate interventions firmly within national strategies, ensure effective implementation, and co-ordinate external 
support with local resources. Health systems performance should be monitored, with clear lines of accountability, and 
reforms should build on evidence of what works in what circumstances.
Introduction
Global Health Initiatives, such as the Global Fund to fight
AIDS, Tuberculosis and Malaria (GFATM), the Global
Alliance for Vaccines and Immunization (GAVI) have
raised large sums of money for essential health care and
have challenged previous notions of what is possible.
However the ability of countries to spend the new funds
effectively is often constrained by fundamental weak-
nesses in their health systems [1-3]. Hence, commenta-
tors have questioned the fragmentation and competing
priorities of many disease-specific programs [4] and
whether they succeed in reaching the poorest groups [5],
while there are broader concerns about their ability to
t a k e  a c c o u n t  o f  n a t i o n a l  c o n t e x t s  [ 6 ] .  T h e r e  i s  a  c l e a r
need to strengthen health systems, given their core role in
delivering services and, especially, their ability to close
the knowledge-action gap [7]. Yet, much of what is writ-
ten has concentrated on diagnosis, with rather less atten-
tion to solutions [2,8]. An extensive review published in
2009 highlighted the limited evidence that Global Health
Initiatives had succeeded in improving national health
systems [9].
Here we review the challenges that face those seeking
to strengthen health systems. Drawing on the framework
proposed in the 2000 World Health Report [10], we view
strengthening as being directed towards the ability of the
entire system to collect, pool, and spend the necessary
finances to become sustainable and equitable, to deliver
effective, appropriate, and equitable care, to generate the
necessary resources (such as a trained workforce) to
make this happen, and to provide the stewardship to
ensure its effective governance. We distinguish this from
the partial strengthening that has so far been undertaken
by several agencies involving directed support for their
own activities, support for a limited set of health systems
functions necessary for the delivery of their own activi-
ties, or integration of their activities into the existing
health system [11].
A major conclusion is the urgent need for evaluative
research to discover what works and in what circum-
stances. First, however, we need to understand what the
problems are. We therefore examine the main health sys-
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tem functions according to the categoriation set out
above, describing key issues that emerge.
The paper combines a review of literature identified
from an initial search of PubMed using combinations of
the terms "health system", strengthen*, full and abbrevi-
ated forms of GFATM and GAVI, vertical and horizontal,
with follow up of relevant citations, and from the litera-
ture collections amassed by the authors over many years
of working in this area (which include a substantial num-
ber of official publications from agencies). The material
used is limited to that published in English. The review
does not seek to provide an exhaustive catalogue of
everything that has been written on this topic, but it does
capture the essential elements and provides a range of
examples to illustrate them.
Health system diagnosis: what are the key problems?
Financing
Those in most need of health care are often least able to
afford it or to judge the quality of care they obtain.
Financing of health systems has three main elements: col-
lection of funds, pooling them, and purchasing effective
care. All three elements often fail. In poor countries weak
infrastructure and enforcement systems mean that pay-
ment of taxes and other contributions are essentially
optional, while in others, what capacity that exists to col-
lect taxes is not fully utilized. Most care is paid for by a
combination of external funds, typically earmarked for
specific conditions, and private out of pocket payments.
Global Health Initiatives have brought substantial addi-
tional resources for particular activities [12]. However,
this means that numerous donor funds and agencies fund
different elements of health systems, with poor co-ordi-
nation impacting adversely on national systems, fragmen-
tation of resources and high transaction costs [1]. This is
often worst in the poorest countries [13]. In addition,
there is now growing evidence that international aid
flows displace overall domestic health expenditure
[14,15], especially in countries in receipt of loans from
the International Monetary Fund[16].
Failure of co-ordination increases burdens on already
pressured national institutions [17]; thus when donor
projects increased from a few hundred to several thou-
sand in Tanzania in the late 1990s the government had to
prepare 2,400 reports every quarter, with senior officials
hosting 1,000 meetings annually[18]. Yet the overall level
of aid remained almost unchanged. The resulting strain
on the system hampered the ability to manage and led to
the introduction of an annual four-month "mission holi-
day" free from meetings with donors.
International funding channels, whether through verti-
cal mechanisms or general budget support, are often dis-
connected from local revenue-generating initiatives, such
as community based health insurance. Scarce local funds
inadequately fill gaps that external funders decline to sup-
port. Multiple financing arrangements make resource
pooling impossible and the myriad of individual transac-
tions from out of pocket payments precludes strategic
purchasing of services from providers. A second problem
is the plight of families faced with catastrophic expendi-
ture due to serious illness [19]. Both have profound con-
sequences for the state; first because it is difficult to
tackle inefficient use of scarce resources and second
because of the macroeconomic consequences as families
hoard money rather than reinvesting it in economic
development [20].
Provision
Traditional vertical programs can succeed in scaling up
basic interventions such as vaccination as long as the
external funding lasts, but they have failed to respond to
the complex challenges now confronting them. Condi-
tions such as AIDS, diabetes, and schizophrenia require
long term relationships between patients and multi-disci-
plinary teams, access to different levels of care, and reli-
able supplies of pharmaceuticals [21]. Those seeking to
scale up treatment for AIDS have recognized that funding
for drugs is not enough [22], a lesson already learned by
those trying to ensure treatment for insulin dependent
diabetes [23]. There are strong theoretical arguments
favoring integrated management of a range of chronic
diseases in primary care settings [24], and although the
evidence for integrating targeted programs with main-
stream services is limited [25], there examples of how
positive synergies can be achieved. Thus, investment in
services for HIV/AIDS in Haiti [26] and Rwanda [27]
improved access to antenatal services and family plan-
ning, as the latter benefitted from investment in new
facilities, laboratories, and training of health workers. In
the African Programme for Onchocerciasis Control, loca-
tions that added other health interventions to their activi-
ties achieved higher uptake of the drug Ivermectin than
those that did not [28].
Resource generation and priority setting
Money is important but not sufficient for strengthening
health systems. Many health systems have limited
absorptive capacity. They face shortages of key staff,
migration, and low skill levels [29]. Human resource poli-
cies must include initial training and life-long learning,
skill-mix and career progression, with appropriate incen-
tives and working conditions [30]. However, these poli-
cies must take account of the substantial obstacles to
change imposed by obsolete structures, institutions, and
beliefs [30,31]. Weak procurement and distribution sys-
tems adversely affect drug supply, exacerbated by coun-
terfeiting and corruption. Government taxes, inefficient
procurement, mark-ups along the distribution chain, and,
in some middle income countries, fee-splitting between
pharmacists and physicians, inflate drug prices [32]. AnBalabanova et al. Health Research Policy and Systems 2010, 8:22
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absence of capital planning and health technology assess-
ment means that technology is often purchased for its
ability to generate fees rather than its appropriateness.
Public health capacity and information systems are weak.
Necessary resources go beyond people and things.
Health systems should also have systems to generate the
knowledge resources they need to function optimally.
Governments attending the 2008 Global Ministerial
Forum on Research for Health in Bamako, Mali, agreed
on the importance of building research infrastructure
into health systems [33,34]. It is only with these knowl-
edge resources, which encompass the production of
research and the creation of systems to ensure that it is
used, that health systems can deliver effective care that is
appropriate for the context in which it is being delivered.
Stewardship
The stewardship function [35], has been especially weak.
In many countries failures of stewardship in the health
sector reflect wider failures of governance in the country
as a whole. The situation is worst in fragile states and
those where democracy is weak, and is exacerbated by the
existence of parallel sub-systems, especially where these
are essentially independent of the state [36]. In many
countries health care is seen as among the most corrupt
sect o rs,  m ani f es t  in a  m yria d of  wa ys  fr om  ove rpric ed
procurement of supplies to informal payments and sales
of counterfeit medications. The net effect is to increase
even further the mismatch between need and supply [37].
Unfortunately, many health systems are unable to estab-
lish the systems that would be needed to prioritize, plan
and deliver the effective policies.
The wider world
Many health systems are already unable to respond ade-
quately to contemporary challenges yet emerging pres-
sures will intensify. Populations are changing, through
both ageing and migration, with the latter likely to be
driven partly by environmental degradation. The threat
from newly and re-emerging infections is ever present.
Products underlying the epidemic of chronic disease in
the west, such as tobacco and energy dense processed
food, are being marketed aggressively in the developing
world. Growing road traffic is resulting in increasing inju-
ries and sedentary lifestyles.
The success of existing initiatives tackling major killers
such as common childhood illnesses means that the bur-
den of disease is now dominated by chronic disorders
requiring complex packages of care. The development of
i n t e g r a t e d  m o d e l s  o f  c a r e  f o r  p e o p l e  w i t h  c o m p l e x
chronic conditions has challenged the richest countries
[38]; there is much less experience in developing coun-
tries [39]. Investment has often been culturally inappro-
priate and useful innovations have been difficult to
implement [40].
Current efforts
The response to contemporary global challenges has led
to proliferation of new institutions and calls for a new
'global architecture' [41]. Several attempts have been
made to improve aid effectiveness, by raising more funds,
harmonizing efforts between donors, and aligning aid
with national priorities. The Paris Declaration, the Accra
Agenda for Action, UNAIDS' 'Three Ones', and the Inter-
national Health Partnership all sought to bring a greater
sense of coherence to both global and national policies.
However, translating goals of harmonization and align-
ment into practice at country level has been slow and dif-
ficult, reflecting competing or conflicting interests and
power of different partners. Put simply, some donors are
more powerful than others, either as a consequence of
the resources they command or because of their status in
the geo-political context. For example, a development
agency from a particular country will be more influential
if that country is also contributing to the defence of the
recipient country against internal or external security
threats. Poor coordination of efforts by external partners
continues to impose high transaction costs on national
health systems [42,43] although there are increasing
examples where Global Health Initiatives support
national co-ordination [44].
Donor alignment and coordination and strengthening
of health systems are being pursued through several
global initiatives (Table 1). The International Health Part-
nership, launched in September 2007, brought together
major donors (the Health 8), western governments, and
health ministers in recipient countries, to examine how to
expand coverage of essential interventions and improve
health outcomes, drawing on the strengths of public, pri-
vate and voluntary sectors. It also provided the secretar-
iat for the recent Taskforce on Innovative International
Financing for Health Systems [45].
This commitment is also apparent in the funding strat-
egies of major donors, including the GFATM and the
GAVI. Indeed the Taskforce process stimulated the
Global Fund, GAVI Alliance and World Bank to propose
a joint mechanism for investment in health systems. Yet
applications to the GFATM focused primarily on health
system strengthening have so far had limited success [46].
Their guidance on what might be supported may not be
aligned with the priorities of recipient countries and thus
may fail to secure political commitment. The World Bank
Strategy for Health, Nutrition, and Population Results
emphasizes "the need to ensure synergy between
enhanced priority-disease financing and strengthening of
health systems, essential for achieving results and
improving DAH [Development Assistance for Health]
effectiveness on the ground"[47], although critics have
argued that the Bank's policies on issues such as the pub-Balabanova et al. Health Research Policy and Systems 2010, 8:22
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Table 1: Examples of the over 75 global health partnerships and initiatives attempting to improve coordination of effort 
among donors and between donors and countries
Global/regional level
Signed Agreements Paris Declaration on Aid Effectiveness (2005) Harmonization of donors and alignment with national priorities 
Indicators for Monitoring & Evaluation
International Health Partnership Global 
Compact (2007)
Improving coordination on national health plans
The 'Three Ones' Harmonization and alignment in HIV/AIDS. UNAIDS, the Global Fund, 
and other agencies.
• one agreed HIV/AIDS action framework which provides the basis 
for coordinating the work of all partners;
• one national HIV/AIDS coordinating authority with a broad-based 
multi-sectoral mandate;
• one agreed country-level system for monitoring and evaluation.
Global Task Team on Improving AIDS 
Coordination among Multilateral Institutions 
and International Donors (2005)
Global Implementation Support Team (2007)
Processes Health 8 agencies (H8) Gates Foundation, GFATM, GAVI Alliance, WB, WHO, UNAIDS, UN 
Population Fund, UNICEF have 6 monthly informal meetings to discuss 
coordination and aid effectiveness issues. Agreed in July 2007 to a 
coordinated health systems strengthening effort, playing a central role 
in co-ordination of IHP+.
Global Campaign for the Health MDGs (26 
September 2007)
 The International Health Partnership
 The Catalytic Initiative (November 2007), by Canada and UNICEF
 Results-Based Financing Initiative (November 2007), by Norway 
and the World Bank.
 Providing for Health Initiative on social health protection, 2008, 
by Germany and France
 Global Leaders Network
 Deliver Now for Women and Children
International Health Partnership and Related 
Initiatives (IHP+) (2007)
Interagency Core Team (based in WHO & WB: and the Harmonisation 
for Health in Africa, based in WHO's Africa Regional Office) Scaling-up 
Reference Group - SURG (representatives of the H-8 agencies, civil 
society and development partners)
Global Health Workforce Alliance
Health Metrics Network
Partnership for Maternal, Newborn and Child 
Health
Medicines Transparency Alliance (MeTA)
Disease specific coordination mechanisms e.g. Stop TB Alliance, and Roll Back MalariaBalabanova et al. Health Research Policy and Systems 2010, 8:22
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lic-private mix expose fundamental contradictions with
these aims [48]. The United Kingdom's Department for
International Development has placed health system
strengthening at the heart of its health strategy, seeing
health systems as key to channeling investment to the
poor [49]. Effective and accessible health systems are
viewed as a key step towards long-term objectives such as
poverty alleviation.
These approaches are being accompanied by a greater
emphasis on the need to develop sustainable financing,
including well-functioning collection systems and risk-
pooling arrangements [50]. The role of donor support
more fundamentally in supporting national health financ-
ing systems has also been advocated, including the scope
for increasing demand through vouchers or payment of
insurance premiums. This approach is also receiving sup-
port from country-level plans and poverty strategies
within SWAps (Sector wide approaches) and Poverty
Reduction Strategy Papers (PRSP). Poverty Reduction
Strategy Papers (PRSPs) are documents required by the
International Monetary Fund and World Bank before a
country can be considered for support within the Highly
Indebted Poor Country programme, designed to relive
the debt burden of the poorest countries. They are pre-
pared by countries by means of a participatory process
involving domestic stakeholders as well as external devel-
opment partners, including the World Bank and Interna-
tional Monetary Fund.
The Sector-Wide Approach (SWAp) is a mechanism
whereby funds from different projects contribute to a
sector-specific (such as health or education) umbrella
that is tied to a defined sector policy under a government
authority. It calls for a new form of partnership between
governments and development agencies, in which the
leadership role of the former is strengthened. Key charac-
teristics include clear ownership and leadership of the
programme by the national government and a common
effort by external partners to support that programme,
including provision of all or a major share of funding for
the sector, in support of the government's unified policy
and expenditure programme.
The high level Taskforce on Innovative International
Financing for Health Systems has called for an additional
$10 bn per year of external assistance by 2015, as well as
substantially increased domestic public financing for
health [45].
What needs to happen within countries to strengthen 
health systems?
Many of the actions required flow directly from weak-
nesses identified earlier. The health systems framework
set out in the 2000 World Health Report draws attention
to the need to focus on otherwise neglected areas, such as
mobilizing resources, risk pooling, and stewardship. In
some areas the degree of underinvestment is clearly
acknowledged, for example the need to increase numbers
of health workers and appropriate 'task shifting'[29]. It is,
however, necessary to look at the system as a whole,
avoiding simplistic checklists for reform [51]. This
demands a coherent vision at the country level of the way
forward, which can then be operationalized through inte-
gration of programs for health problems that share com-
mon characteristics, such as chronic diseases,
interlinkage of inputs, and coordination between levels of
care, sectors, and policies, all based on effective commu-
nication between patients (and communities), practitio-
ners, and policy-makers. Strong country leadership and
political commitment have been crucial factors in inte-
grating disease-specific programs within broader delivery
systems (e.g. HIV scale-up in Brazil and Thailand), within
national primary health care strategies and information
systems (Dominica), and in creating linkages to training
National level SWAps
PRSps (health system interventions integrated in a poverty reduction 
strategies)
IHP+ country compacts
Country Coordinating Mechanisms for GF
One-UN, 2007 (all UN agencies under one roof, a lead agency, one budgetary 
framework)
UN 'cluster approach' In emergency settings/chronic conflict whereby one UN agency is 
responsible for taking the lead in coordination with the government.
Table 1: Examples of the over 75 global health partnerships and initiatives attempting to improve coordination of effort 
among donors and between donors and countries (Continued)Balabanova et al. Health Research Policy and Systems 2010, 8:22
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and optimizing skill mix of workers (Ethiopia,
Malawi)[52].
The traditional distinction between vertical (disease-
specific) and horizontal approaches is being reassessed.
Each has strengths and weaknesses. Where health sys-
tems are extremely weak, vertical programs can play an
important role, but they need to be designed in ways that
act as a catalyst for wider system change (as is being
attempted by the GFATM and GAVI), becoming interwo-
ven in a matrix with horizontal programs [2]. It is also
possible to sequence vertical and horizontal approaches
in ways that enhance outcomes and build sustainable and
locally relevant long term capacity [8]. One manifestation
are the so-called 'diagonal programs'[53] being explored
by the GFATM, where system-wide investment includes a
degree of support to specialized disease functions [54].
These involve a "strategy in which we use explicit inter-
vention priorities to drive the required improvements
into the health system, dealing with such generic issues as
human resource development, financing, facility plan-
ning, drug supply, rational prescription, and quality
assurance." [55]
Taking the example of the Global Fund, Ooms et al.
argue that diagonal approaches to financing (aiming for
disease-specific results through improved health sys-
tems) can be an intermediary step towards horizontal
financing involving coordination and integration of dis-
ease-specific interventions into the broader health sys-
tems [14].
According to WHO, diagonal approaches reconcile the
need to keep some specialised functions while recognis-
ing that programmes and their scaling up require stron-
ger health systems. A related concept is that of
"integration of service delivery", links between prevention
and treatment, between different stakeholders, between
public, voluntary and private sectors, and between levels
of the health system.
Such approaches offer scope to benefit from synergies
in the management of different diseases, particularly for
complex chronic disorders such as AIDS, diabetes, and
cardiovascular disease. All require functioning pharma-
ceutical distribution systems and mechanisms to train
staff in areas as diverse as management, quality assur-
ance, information systems and palliative care but it is
wasteful to organize each of them separately. Yet achiev-
ing synergies will often require considerable effort to
overcome historical patterns of provision, based on
established funding streams, hierarchies, training and
clinical routines that serve the interests of the provider
rather than the patient.
This highlights the importance of paying attention not
only to the design of health systems strategies but also to
the implementation of change and the ways of overcom-
ing the factors that hamper it [56]. There is a need to
acknowledge the diversity of skills, motivations, and
beliefs among those with a stake in health systems,
understanding how community-level influences, profes-
sional interests and informal relationships between actors
influence how programs are implemented and the degree
to which they achieve their goals.
For this to happen, there is a need to realign the focus
of much existing research, based on a better understand-
ing of how health systems develop and change in different
contexts. Too often in the past it has been assumed that a
policy developed in one setting will work in another and,
even when it is clear that the policy has failed, there is lit-
tle interest in asking what it was about the context into
which it was transplanted that caused it to do so. This
requires a greater understanding of the concept of path
dependency whereby, in the absence of a severe shock to
the broader political system, the development of a health
system is constrained by the history, culture, economic
development, and institutional structures (especially
labor relations, systems of government, and the rule of
law) of the country in which it is situated [6,57]. These
must be understood if realistic reform strategies are to be
developed. Hence, research on barriers to implementa-
tion must consider not only the outcomes and impacts of
reform outcomes but also the processes involved and the
context in which they take place.
What changes are needed in the global aid architecture 
and how can they be implemented?
Improved health systems functioning demands change in
the global aid architecture. Key issues include coordina-
tion, comprehensiveness, continuity, capacity, and
accountability.
Health systems strengthening can give the impression
of becoming simply the latest fashion, with many actors
now becoming engaged through funding, agenda setting,
provision of technical advice, and oversight of implemen-
tation. This can bring benefits, as each actor can have
competitive advantages, based on skills, areas of exper-
tise, and established links but also poses challenges.
These actors must fulfill a number of different roles.
While almost all provide some degree of technical assis-
tance, some are primarily donors providing funds to
strengthen health systems, some of whom will focus on
specific diseases or interventions, such as the GF A TM,
GAVI, and PEPFAR, while others take a broader perspec-
tive on the overall health system (and beyond), typified by
bilateral development agencies such as DFID, DANIDA,
and SIDA. Both types have a responsibility to ensure that
they recognize the complex interlinkages between their
various activities. They also must ensure that the evi-
dence base for policy and practice is strengthened, avail-
able evidence is acted upon in programs that they fund,
and that these programs contribute to health systemBalabanova et al. Health Research Policy and Systems 2010, 8:22
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strengthening in effective and transparent ways. Exam-
ples include developing a cadre of health workers that can
contribute to health system priorities and not just a single
disease, supporting sustainable health system financing
mechanisms, and putting in place quality assurance sys-
tems which can cover a range of health outcomes. How-
ever, efforts by donors to invest in disease-specific
programmes that also contribute to system-building are
hampered by the limited evidence on what activities actu-
ally result in strengthening health systems and under
what conditions [11].
Others have a normative role in addition to the techni-
cal assistance they provide at country level. These include
the WHO and, in some respects, the World Bank. Their
role should be to ensure that the best available evidence is
used to inform the development and implementation of
effective policies, activities that have recently been
endorsed by the leaders of eight of the global health agen-
cies, including the WHO, World Bank, GFATM, and
GAVI [58].
These roles are clearly complementary but the
increased global engagement in health systems strength-
ening is leading to considerable fragmentation in priori-
ties and strategies [47,59]. The challenge is how to reap
the benefits of this diversity while ensuring that activities
are, at best, aligned with each other and with what coun-
tries want (i.e. follow country priorities and needs and are
context specific) and, at least, are not in conflict. There is
certainly a view among many recipient countries that this
process must start at country level and build on existing
coordination processes nationally [60].
This analysis implies a need for leadership. Yet it is far
from clear where this leadership should come from.
Although the WHO views itself, and is viewed by many
others, as occupying a position of leadership in global
health, the complementarities of the many specialized
institutions involved means that there may be different
leaders in different situations. Rather, it seems that there
is a need for dynamic partnerships in which different
institutions lead in different areas, but in ways that sup-
port rather than undermine the work of others. These
partnerships should support leadership by developing
countries and South-South coalitions as far as possible
[60]. Where there is strong country leadership, as in
Rwanda, partnerships do work well. Furthermore,
involvement of the international private and voluntary
sectors in these coordination processes is vital given their
important role in the health systems of many countries.
There are already some positive developments seeking
to improve the effectiveness and predictability of aid
flows and reduce duplication across donors and imple-
menting agencies [61]. However, the linkages between
initiatives are not always clear. Coordination is also
needed within organizations: there is a risk that health
systems support is viewed as yet another initiative, sepa-
rate from what is taking place to provide disease-specific
support. There is encouraging evidence that this is being
avoided, for example in the Global Health Initiatives [62],
health systems support is beginning to be viewed as cut-
ting across programs within agencies (GFATM, GAVI)
rather than as free-standing units within agencies,
although experience with such arrangements is so far
limited.
The diversity of actors in part reflects a multiplicity of
interests. Agencies such as the GFATM and GAVI have
clear mandates to focus on specific elements of health
care. Non-governmental and private donors have also
carved out niches, often focused on individual diseases.
However, policies on health systems are more vulnerable
than disease control policies to ideological influences, as
evident in controversies over user fees and social health
insurance, with donors often influenced by their own
health service traditions and cultures. Effective coordina-
tion requires agreement on both investment priorities for
health systems strengthening and implementation strate-
gies. Aligning disbursement procedures is likely to pose
challenges and will require significant commitment from
both donor and recipient governments and a willingness
to sacrifice some direct control over funding for greater
aggregate impact. This will require greater independent
evaluation of aid effectiveness over sustained periods.
Experience with SWAps highlights both the impor-
tance and difficulties of pooling resources, agreeing pri-
orities, coordinating reporting systems, monitoring, and
embedding aid flows within national plans and budgets as
a pre-requisite for creation of comprehensive approaches.
Although experience has varied, where SWAps have been
effective, as in Uganda, they have helped governments to
develop strategic oversight over policies and resources,
while working in partnership with donors and imple-
menting agencies [63]. Yet there is a constant threat from
disease-led funding focused on short project cycles, with
"deliverables" that are not aligned with national priorities
[64] but which serve donor interests to demonstrate
quick results. An analysis of Overseas Development
Assistance for maternal, neonatal and child health dem-
onstrates that there was virtually no change between
2003 and 2006 in the share of project funding, and that
project funding dominates sector and budget support
[65] (Table 2). Experience with SWAps also demonstrates
the technical challenges; differences in accountability and
reporting mechanisms have prevented Global Health Ini-
tiatives being placed within them [62].
Some have argued for an explicit focus on the extent to
which funding achieves demonstrable synergies [22], with
others linking this to calls for improved monitoring ofBalabanova et al. Health Research Policy and Systems 2010, 8:22
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global and national actors by independent institutions or
coalitions, to improve donor accountability in general
and to recipient countries in particular [60].
The SWAp experience highlights the importance of
continuity, based on stable relationships among the major
international actors and with recipient countries, and the
ability to rise above the turbulence caused by short term
priorities, funding cycles, and transient personal agendas.
This requires a sustained focus on long-term objectives
[49], eschewing of donor shifts towards 'fashionable' ini-
tiatives. However, in many cases this will require a new
mindset among those involved and a commitment from
'recipient' governments to maintain their investment in
health when donors are making substantial contributions.
Just as at national level, there is a need to boost capacity
at international level. As already noted, the body of
knowledge that can be drawn upon to guide decision
making is limited and there is often inadequate under-
standing of the extent to which findings are contextually
bounded. Many major donors and national governments
face difficulties in recruiting individuals with appropriate
skills and experience but this problem is especially great
in the area of health systems. Translation of research into
policy-relevant messages is often weak, with considerable
scope to develop and evaluate cadres of knowledge bro-
kers to function as intermediaries between researchers
and policymakers [66]. Although communication
involves transmission and reception, there has often been
inadequate investment in the creation of research aware
policy-makers and practitioners in recipient countries.
This is, however, being addressed in an important new
initiative, EVIPNet, (Evidence-Informed Policy Network
For Better Decision Making) [67]. This is a WHO initia-
tive that brings together researchers, policy makers and
civil society to facilitate the use of high quality research
evidence by policy-makers in low and middle-income
countries.
Finally, there is a need to strengthen systems of
accountability, at global, national and sub-national level.
This will never be easy, given the diversity of bodies
involved and the fact that development assistance is
intrinsically political. There is also a need for a better
understanding of the role of the private and voluntary
sectors, the interests they represent, and the ways in
which they can be held accountable. Governments and
private donors cannot be made to do something they
would otherwise not do. However, they are not immune
from public opinion, especially when a light is shone on
their activities by non-governmental agencies, such as
Global Health Watch [68].
Conclusions
The need for health systems support to recipient coun-
tries now appears well accepted, but there is currently no
clear way forward as to how this should implemented.
Indeed, there is a risk that efforts to address health sys-
tem strengthening will simply aggravate the current
crowded scene of diverse global initiatives. Simply adding
health system funding streams to existing global initia-
tives is not enough. There needs to be radical action to
simplify the global health architecture and reduce the
transactions costs they impose on countries. Five key
actions are needed.
First, there is a need for agreement on which interna-
t i o n a l  a g e n c i e s,  o r  p a r t n e r s h i p s,  s h o u l d  be  i n v o l v e d  i n
health systems strengthening and in what ways, taking
into account their mandates, expertise, and comparative
advantage [69]. In particular, there is a need for clarity on
who can provide leadership and on the roles of the WHO
and the World Bank. It will also be important to learn les-
sons from the implementation of the International Health
Partnership.
Second, it is vital that recipient countries should have,
or should be supported to develop, a coherent national
strategy for prioritizing external support and managing it
together with local resources in a coordinated way. There
should be effective agreements that standardize health
worker remuneration, so that one initiative does not
poach staff from another, although reaching such agree-
ments may be difficult as they must take account of local
labor market conditions and, especially, the need for
some form of equivalence with the private sector. Parallel
systems should not be created, whether to procure drugs
or account for expenditures. Given the scarcity of
resources for delivery of care, agencies that provide dis-
ease specific funding should be required to ensure they
do not free-ride on a health system infrastructure which
they do not support.
Third, while many countries require greater technical
capacity in managing and controlling specific diseases,
and national or regional disease control programs have
considerable value, it is vital that disease control activities
are integrated with other health services at the level of
service delivery. In particular, there are substantial syner-
gies in delivery of care to those with AIDS and non-com-
municable diseases, both of which require well-managed
pharmaceutical supply chains, trained multi-professional
teams, and management systems to support long-term
relationships between patients and health care providers
at different levels of the system. The exceptions would be
where the nature of the intervention is such that it is free-
standing - as with national media campaigns, for exam-
ple, or interventions in other sectors such as schools.
Fourth, advocates of health system support need to give
more careful thought to how the success of health sys-
tems strengthening can be assessed. Historically, health
systems have been seen as not just a black box but also a
black hole, absorbing resources without visible resultsBalabanova et al. Health Research Policy and Systems 2010, 8:22
http://www.health-policy-systems.com/content/8/1/22
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[51]. The challenge is to hold health systems accountable
for performance, but without resorting to narrow targets
that can distort behavior, as has been the experience in
the UK NHS, for example [70]. It is easy to see how the
unsophisticated use of targets might encourage an orga-
nization to concentrate its efforts in urban areas where
populations are most accessible, to the detriment of those
in remote settings [71] or, as described with the GFATM's
activities in Nicaragua, might create pressure to sacrifice
quality for quantity [72].
Finally, the evidence base from which countries can
draw examples of successful approaches to improving
health systems performance is extremely weak. There is
an urgent need for greater investment in applied health
systems research in low income countries, especially that
focusing on implementation of effective approaches to
improving health system performance, including training
of researchers and strengthening of research institutions
[73]. This investment should recognize the importance of
research and evaluation that draws on a wide range of
disciplinary perspectives and uses both quantitative and
qualitative methods. This should increase the evidence
base for system interventions as well as develop methods
for monitoring progress. Such research should take
account of the effect of context on implementation,
where possible embedding analysis in a systems frame-
work that recognizes the existence of complexity, charac-
terized by dynamic relationships, variable time lags and
feedback loops [74,75]. Approaches which help translate
evidence into policy, such as knowledge broking initia-
tives like EVIPNet must also be supported.
Successful implementation of these five steps should
increase the prospects substantially for attainment of the
MDGs, as well as enabling health systems to respond to
other health challenges.
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